Get started
Dr_Tabb

Incoming Buying Opportunity

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
Dr_Tabb  
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Trend Analysis
0
0
trendanalysis
REGN potentially coming into $460 range again.
R/R heavy in favor going long if it falls to this level.
Would keep watch.
Recent phase 3 results re:COVID19
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.